▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3066 by analyst upside · 2026-09-27
AVAH
Aveanna Healthcare Holdings Inc.
Healthcare · Market Cap $3B · P/E 9.8x
ANALYST PRICE TARGET
+17.6%
implied upside to consensus target
Current Price $12.41
Consensus Target $14.6
Bull Target $16.0
Bear Target $13.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
5
Hold
3
Sell
0
52-Week Low $5.93
52-Week High $14.71
YTD Return +53.6%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) 9.8x
Forward P/E 13.7x
EPS (TTM) $1.26
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2.6B
Profit Margin 10.6%
52-WEEK RANGE
52-Week Low $5.93
52-Week High $14.71
Current Price $12.41
Bear Target $13.0
Bull Target $16.0
● Now $12.41 ● Target $14.6
TRADING DATA
Avg Volume 2.9M
YTD Return +53.6%
Analyst Count 10
Consensus Buy
Upside to Target +17.6%
Last Updated 2026-09-27

ANALYST SUMMARY

Aveanna Healthcare Holdings Inc. (AVAH) is currently trading at $12.41 with a Wall Street consensus price target of $14.6, implying potential upside of 17.6% over the next 12 months. 10 analysts currently cover AVAH, with a consensus rating of Buy - 70% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $16.0, while the most cautious has a target of $13.0.

AVAH operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 53.6% year-to-date and is currently trading near the upper end of its 52-week range of $5.93 – $14.71.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HRMY +14.8%
Harmony Biosciences Holdings, Inc.
$2B · P/E 13.4x · Buy
AUPH +8.6%
Aurinia Pharmaceuticals Inc.
$2B · P/E 7.2x · Buy
TMDX +14.1%
TransMedics Group, Inc.
$3B · P/E 22.1x · Buy
MD +0.1%
Pediatrix Medical Group, Inc.
$2B · P/E 12.6x · Hold
PBH +45.5%
Prestige Consumer Healthcare Inc.
$2B · P/E 13.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AVAH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Neutral → Neutral 2026-09-14 43% win rate (7 calls)
Barclays - Reiterated
Overweight → Overweight 2026-08-28 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-08-24 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-08-24 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-14 33% win rate (6 calls)
Raymond James - Reiterated
Strong Buy → Strong Buy 2026-08-14 Building track record
BMO Capital - Reiterated
Outperform → Outperform 2026-08-14 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-07-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
18/30
Consensus clarity
25/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →